Accelerating research on Duchenne muscular dystrophy and genetic diseases

Learn more about the origins of a unique story

Read the story

Meet a selection of the scientists and doctors supported by the Only Project

Read the story

We support fundamental and applied research, with a focus on developing therapies

Read the story

Announcing our new Pioneers Grant with funding starting at €500,000 per project, with the potential to reach up to €2 million

Learn more here

We raise funds to finance fundamental and applied research on Duchenne muscular dystrophy and genetic diseases.

24 years of existence 

€129 million raised

50+ researchers supported  

2 biotechs created

Our mission

Our goal is to accelerate research on a therapy for Duchenne muscular dystrophy and do everything we can to advance research on neuromuscular and genetic diseases and to alleviate suffering linked to these conditions.

Read more

For 20+ years, we have been supporting researchers around the world

We support medical and scientific research aimed at finding effective treatments and cures for neuromuscular diseases, with an emphasis on Duchenne muscular dystrophy.

Learn more about supported projects

Some recent highlights

We present our latest advances, upcoming events or our latest research.

Read latest news

May 24, 2025

2024 Annual Report and Audited Financial Statements

The year 2024 marked a major turning point for AMM-Only Project. It was defined by continued progress on the clinical trial of SQY51, a promising drug candidate developed by SQY Therapeutics which was co-founded and…

Read the news

March 18, 2024

Audit reports for fiscal years 2023, 2022, 2021

Created in 2001 and essentially constituted of parents of sick children, AMM contributes to accelerating research into Duchenne muscular dystrophy, which affects 1 in 3,500 boys and leads to progressive weakening of all muscles, including…

Read the news

October 16, 2023

How the charity works and distributes funds

Only Project is a common umbrella for all projects supported by the Association Monégasque contre les Myopathies (AMM) via the funds raised from Only Watch and donations. AMM was launched in 2001 by a group…

Read the news

June 15, 2023

Beginning of a Phase 1 clinical trial: what to expect?

Read the news